Oct 8, 2007 by Billy FisherVital Signs at MedtronicThe FDA raises question about Medtronic's Endeavor stent.
Oct 5, 2007 by Billy FisherDueling Fools: Washington Mutual BearRecent turmoil in the mortgage industry paints a bleak outlook for the company.
Oct 5, 2007 by Billy FisherDueling Fools: Washington Mutual Bear RebuttalOutperformance is unlikely, so why not put your money elsewhere?
Oct 4, 2007 by Billy FisherOn Target at Northrop GrummanNorthrop Grumman reaffirms its fiscal '07 earnings outlook.
Oct 4, 2007 by Billy FisherImmucor Draws First BloodThe company sees double-digit growth in both sales and earnings in Q1.
Oct 4, 2007 by Billy FisherIsis Keeps Cholesterol Down, Stock Prices UpIsis Pharmaceuticals reports positive phase 2 results for a cholesterol treatment.
Oct 2, 2007 by Billy FisherClosure for Bristol-MyersThe drug company will pay $515 million to resolve cases from state and federal authorities.
Sep 27, 2007 by Billy FisherBaxter Looking to Bounce BackThe shares rebound after the company recalled a product.
Sep 26, 2007 by Billy FisherMore Than 40 Winks From ArenaSubjects fall asleep and stay asleep with the company's insomnia drug, clinical trials show.
Sep 25, 2007 by Billy FisherBristol-Myers Buys In to BiologicsIt shifts its focus by acquiring Adnexus Therapeutics for $430 million.
Sep 24, 2007 by Billy FisherGetting It Done at Meridian BioscienceImpressive earnings growth and disciplined spending continue to propel this small cap up and up.
Sep 24, 2007 by Billy FisherA Fountain of Youth?Sirtris-sponsored study shows potential for the fight against aging.
Sep 20, 2007 by Billy FisherMore Options for Healthy Bones?Novartis and Wyeth might be able to offer alternative treatments for osteoporosis.
Sep 19, 2007 by Billy Fisher6 Stocks Getting a Boost From Uncle SamDefense contractors continue to prosper with increased government spending on defense.
Sep 19, 2007 by Billy FisherPrevnar Problems at Wyeth?New strains of bacteria might make the popular vaccine less effective.
Sep 11, 2007 by Billy FisherFDA Takes Issue With Boston ScientificBoston Scientific receives a warning letter from the FDA on a discontinued stent trial.
Sep 7, 2007 by Billy FisherEpic Vioxx Victory for MerckNew Jersey Supreme Court rules against the possibility of a national class action Vioxx lawsuit.
Sep 6, 2007 by Billy FisherA Cheap Jewel?Shares of Signet hit a new 52-week low, even as profits improve.
Sep 5, 2007 by Billy FisherLilly's Pipeline Continues to ProduceAnother schizophrenia drug from the company shows promise in a clinical trial.
